A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/5377 (2006.01)
Patent
CA 2587590
This invention features pyrimidine compounds of formula (I): Rl is formula (A), aryl, or heteroaryl; each of R2 and R4, independently, is Rc, halogen, nitro, cyano, isothionitro, SRc, or ORc; or R2 and R4, taken together, is carbonyl; R3 is Rc, alkenyl, alkynyl, ORc, OC(O)Rc, SO2Rc, S(O2)NRc Rd, NRcCORd, NRcC(O)ORd, NRcC(O)NRcRd, NRcSO2Rd, CORc, C(O)ORc, or C(O)NRcRd; R5 is H or alkyl; n is 0, 1, 2, 3, 4, 5, or 6; X is O, S, S(O), S(O2), or NRc; Y is a covalent bond, CH2, C(O), C=N-Rc, C=N-ORc, C=N-SRc, O, S, S(O), S(O2), or NRc; Z is N or CH; one of U and V is N, and the other is CRc; and W is O, S, S(O), S(O2), NRc, or NC(O)Rc; in which each of Ra and Rb, independently, is H, alkyl, aryl, heteroaryl; and each of Rc and Rd, independently, is H, alkyl, aryl, heteroaryl, cyclyl, heterocyclyl, or alkylcarbonyl. The featured compounds inhibit the production of IL-12, IL-23 and IL-27 and are useful for treating disorders associated with IL- 12, IL-23 and IL-27 overproduction or misregulation, such as inflammatory and immune disorders.
La présente invention concerne des composés de pyrimidine de formule (I) dans laquelle: R1 est un composé de formule (A), aryle, ou hétéroaryle; R2 et R4 sont chacun indépendamment Rc, halogène, nitro, cyano, isothionitro, SRc, ou ORc; ou R2 et R4, forment ensemble carbonyle; R3 est Rc, alcényle, alcynyle, ORc, OC(O)Rc, SO2Rc, S(O)Rc, S(O2)NRc Rd, SRc, NRcRd, NRcCORd, NRcC(O)ORd, NRcC(O)NRcRd, NRcSO2Rd, CORc, C(O)ORc, ou C(O)NRcRd; R5 est H ou alkyle; n vaut 0, 1, 2, 3, 4, 5, ou 6; X est O, S, S(O), S(O2), ou NRc; Y est une liaison covalente, CH2, C(O), C=N-Rc, C=N-ORc, C=N-SRc, O, S, S(O), S(O2), ou NRc; Z est N ou CH; U ou V est N, alors que l'autre est CRc; et W est O, S, S(O), S(O2), NRc, ou NC(O)Rc; Ra et Rb étant indépendamment H, alkyle, aryle, hétéroaryle; et Rc et Rd étant chacun indépendamment H, alkyle, aryle, hétéroaryle, cyclyle, hétérocyclyle, ou alkylcarbonyle. Les composés de l'invention inhibent la production de IL-12, IL-23 et IL-27, et sont utiles pour traiter des troubles associés à la surproduction ou la mauvaise régulation de IL- 12, IL-23 et IL-27, tels que les troubles inflammatoires et les troubles immuns.
Hsia Albert Y.
Lu Rongzhen
Wada Yumiko
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Synta Pharmaceuticals Corp.
LandOfFree
Pyrimidine compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrimidine compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds and uses thereof will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2049381